Equillium, Inc. (NASDAQ:EQ) went up by 16.08% from its latest closing price compared to the recent 1-year high of $27.05. The company’s stock price has collected 13.04% of gains in the last five trading sessions. Press Release reported 10 hours ago that Equillium Announces Successful Completion of FDA Pre-IND Meeting Enabling Advancement of Itolizumab into a Potential Registration Study as a Treatment for Hospitalized COVID-19 Patients
Is It Worth Investing in Equillium, Inc. (NASDAQ :EQ) Right Now?
The average price from analysts is $18.75, which is -$6.64 below the current price. EQ currently public float of 13.30M and currently shorts hold a 3.59% ratio of that float. Today, the average trading volume of EQ was 2.72M shares.
EQ’s Market Performance
EQ stocks went up by 13.04% for the week, with a monthly drop of -35.15% and a quarterly performance of 97.92%, while its annual performance rate touched 50.13%. The volatility ratio for the week stands at 11.65% while the volatility levels for the past 30 days are set at 9.28% for Equillium, Inc.. The simple moving average for the period of the last 20 days is 9.82% for EQ stocks with a simple moving average of 34.34% for the last 200 days.
Analysts’ Opinion of EQ
Many brokerage firms have already submitted their reports for EQ stocks, with H.C. Wainwright repeating the rating for EQ by listing it as a “Buy.” The predicted price for EQ in the upcoming period, according to H.C. Wainwright is $24 based on the research report published on July 14th of the current year 2020.
Stifel, on the other hand, stated in their research note that they expect to see EQ reach a price target of $10, previously predicting the value of $22. The rating they have provided for EQ stocks is “Buy” according to the report published on July 10th, 2020.
SVB Leerink gave a rating of “Outperform” to EQ, setting the target price at $16 in the report published on February 22nd of the previous year.
EQ Trading at -24.60% from the 50-Day Moving Average
After a stumble in the market that brought EQ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.45% of loss for the given period.
Volatility was left at 9.28%, however, over the last 30 days, the volatility rate increased by 11.65%, as shares sank -3.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +142.12% upper at present.
During the last 5 trading sessions, EQ rose by +32.56%, which changed the moving average for the period of 200-days by +109.82% in comparison to the 20-day moving average, which settled at $6.03. In addition, Equillium, Inc. saw 69.23% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at EQ starting from Connelly Stephen, who sold 250,000 shares at the price of $8.13 back on Jul 13. After this action, Connelly Stephen now owns 1,043,000 shares of Equillium, Inc., valued at $2,033,475 using the latest closing price.
Keyes Jason A, the Chief Financial Officer of Equillium, Inc., sold 5,000 shares at $5.03 during a trade that took place back on Feb 18, which means that Keyes Jason A is holding 130,520 shares at $25,138 based on the most recent closing price.
Stock Fundamentals for EQ
The total capital return value is set at -45.90, while invested capital returns managed to touch -43.96. Equity return is now at value -70.50, with -52.40 for asset returns.
Based on Equillium, Inc. (EQ), the company’s capital structure generated 23.13 points at debt to equity in total, while total debt to capital is 18.79. Total debt to assets is 17.43, with long-term debt to equity ratio resting at -95.80. Finally, the long-term debt to capital ratio is 23.13.